Cite
HARVARD Citation
Krause, T. et al. (2021). A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report. Journal der Deutschen Dermatologischen Gesellschaft. pp. 1781-1783. [Online].